Who owns BRIDGEBIO PHARMA INC?
- CUSIP Number: 10806xad4
Tip: Access positions for across all investors
Analyze quarterly positions in Bridgebio Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Bridgebio Pharma stock
Who bought or sold BRIDGEBIO PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Linden Advisors | 175M | $173M | 18% | Sep 2025 |
|
| Wolverine Asset Management | 45M | $44M | 0% | Sep 2025 |
|
| Camden Asset Management | 34M | $34B | 100% | Sep 2025 |
|
| Sona Asset Management | 31M | $31M | 0% | Sep 2025 |
|
| Ing Investment Management | 30M | $30M | -75% | Sep 2025 |
|
| Steelhead Partners | 30M | $30B | 114% | Sep 2025 |
|
| Davidson Kempner Capital Management | 30M | $30M | 0% | Sep 2025 |
|
| MacKay Shields | 29M | $29M | 0% | Sep 2025 |
|
| D. E. Shaw & Co | 29M | $28M | 30% | Sep 2025 |
|
| Jump Financial | 28M | $28M | 100% | Sep 2025 |
|
| Wells Fargo & Company | 23M | $23M | -4% | Sep 2025 |
|
| Advent Capital Management | 22M | $21M | 41% | Sep 2025 |
|
| Laurion Capital Management | 19M | $19M | 0% | Sep 2025 |
|
| State Street Corporation | 15M | $15M | 3% | Sep 2025 |
|
| Lazard Asset Management | 13M | $127k | 7% | Sep 2025 |
|
| Oaktree Capital Management | 11M | $11M | -40% | Sep 2025 |
|
| Nuveen | 10M | $9.8M | 100% | Sep 2025 |
|
| Silverback Asset Management | 9.5M | $9.3M | -27% | Sep 2025 |
|
| FMR | 8.7M | $8.5M | -5% | Sep 2025 |
|
| BlackRock | 7.2M | $7.0M | 0% | Sep 2025 |
|
| Shenkman Capital Management | 6.7M | $6.8B | 100% | Sep 2025 |
|
| SSI Investment Management | 5.5M | $5.4M | 0% | Sep 2025 |
|
| Calamos Advisors | 5.0M | $4.9M | -50% | Sep 2025 |
|
| Jpmorgan Chase & Co | 4.1M | $4.0M | 100% | Sep 2025 |
|
| Ameriprise Financial | 3.5M | $3.4M | -71% | Sep 2025 |
|
| New York State Common Retirement Fund | 2.9M | $2.8M | -6% | Sep 2025 |
|
| Bnp Paribas Investment Partners | 2.5M | $2.5M | 0% | Sep 2025 |
|
| Palisade Capital Management | 2.0M | $2.0M | 0% | Sep 2025 |
|
| Morgan Stanley | 1.8M | $1.7M | 100% | Jun 2025 |
|
| Bnp Paribas Arbitrage, Snc | 1.7M | $1.6M | 100% | Sep 2025 |
|
| Russell Investments | 1.7M | $1.6M | -49% | Sep 2025 |
|
| CSS | 1.5M | $1.5M | -76% | Sep 2025 |
|
| Goldman Sachs Group | 1.5M | $1.4M | -90% | Sep 2025 |
|
| UBS Group | 750k | $738k | 100% | Sep 2025 |
|
| Universal- Beteiligungs- und Servicegesellschaft mbH | 600k | $595k | 0% | Sep 2025 |
|
| Sei Investments | 271k | $267k | 0% | Sep 2025 |
|
| Bank of New York Mellon | 200k | $198k | 0% | Sep 2025 |
|
| Barclays | 126k | $125k | 100% | Sep 2025 |
|
| Context Capital Management | 98k | $97M | 35% | Sep 2025 |
|
| ADAR1 Capital Management | 45k | $4.4M | -99% | Sep 2025 |
|
| Insigneo Advisory Services | 16k | $16k | 100% | Sep 2025 |
|
| Wealth Enhancement Advisory Services | 12k | $12k | 100% | Sep 2025 |
|
| SG Americas Securities | 10k | $1.0M | -37% | Sep 2025 |
|
Who sold out of Bridgebio Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Aristeia Capital | Jun 2025 | 28M | $26M |
| Healthcare Of Ontario Pension Plan Trust Fund | Jun 2025 | 13M | $12M |
| Millennium Management | Jun 2025 | 5.0M | $4.7M |
| HighTower Advisors | Jun 2025 | 4.0M | $3.7M |
| Toronto-Dominion Bank | Jun 2025 | 1.2M | $1.1M |